Mirataz for Cats – Appetite Stimulant for Managing Weight Loss
Mirataz (mirtazapine transdermal ointment) is a prescription medication formulated to manage weight loss in cats suffering from various underlying health conditions. It is the first and only FDA-approved transdermal medication designed specifically for feline weight management. By stimulating appetite and increasing food intake, Mirataz helps cats regain and maintain their body weight without the need for oral administration.
Feline weight loss can be a symptom of serious medical conditions, including hyperthyroidism, chronic kidney disease, inflammatory bowel disease (IBD), neoplasia, pancreatitis, and liver failure. Cats experiencing these conditions often suffer from reduced appetite, which leads to malnutrition, muscle wasting, and further health complications. Mirataz provides an effective and well-tolerated solution for encouraging weight gain in affected cats.
How Mirataz Works
Mirataz contains the active ingredient mirtazapine, an antidepressant with appetite-stimulating properties. In cats, mirtazapine acts as a serotonin and histamine receptor antagonist, which helps to increase appetite, reduce nausea, and improve food consumption.
Unlike traditional oral medications, Mirataz is formulated as a transdermal ointment. It is applied directly to the inner pinna (ear flap) of the cat’s ear, allowing the medication to be absorbed through the skin. This method of administration eliminates the stress associated with giving pills or liquids, making it easier for both cats and their owners to manage treatment.
VETERINARY PRESCRIPTION REQUIRED
